Investors

 

Novartis Venture Funds

 
Novartis Venture Funds, established in 1996, currently has over $750 million under management and is invested in more than 65 private companies. Novartis Venture Funds invests in companies that have the potential to lead the next innovation wave in core therapeutic fields or explore new business areas that will be critical to patient care. The NVF team of ten investment professionals located in Basel, Switzerland and Cambridge, MA, brings together extensive experience in R&D and venture capital.  
www.venturefund.novartis.com  

Truffle Capital

Founded in 2002 in Paris, Truffle Capital is a leading independent European private equity firm dedicated to investing in and building technology leaders in the IT, life sciences and energy/sustainable development sectors. With €460 million in managed funds, Truffle Capital is led by a team of four partners (Jean-François Fourt, Henri Moulard, Philippe Pouletty and Bernard-Louis Roques) with decades of successful investment and entrepreneurial experience in both Europe and North America. Truffle Capital aims to achieve superior financial returns by leveraging its industry knowledge, extensive network, operational experience and focus on spin-outs to identify business opportunities that match latent market needs.
www.truffle.com

Gran Plasa SAl

Gran Plasa SA, a private fund based in Fribourg, Switzerland, invests in high-tech; construction; and real-estate companies in Switzerland and across Europe.